nicotine has been researched along with Nervous System Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bridge, MF; Fannin, RD; Gerrish, KE; Letsinger, AC; Mahapatra, D; Sills, RC; Ward, JM; Yakel, JL | 1 |
| Melis, M; Pistis, M | 2 |
| Bonnier, C; Fiasse, L; Galanti, L; Godding, V; Lebecque, P; Longueville, E; Michel, M; Robert, A | 1 |
| Angstman, SE; Ebbert, JO; Enoch, CC; Gill, L; Hurt, RD; Moyer, TP; Offord, KP; Patten, CA; Renner, CC; Schroeder, DR | 1 |
| Choi, JH; Dresler, CM; Gamble, ML; Marsh, HS; Strahs, KR; Targett, DA | 1 |
| Brower, V | 1 |
| Garcia-Algar, O; Pichini, S | 1 |
| Desagher, S; Glowinski, J; Marin, P; Maus, M; Prémont, J | 1 |
| Dempsey, DA; Ferriero, DM; Good, W; Hajnal, BL; Jacobson, SN; Jones, RT; Partridge, JC | 1 |
| Harris, BR; Littleton, JM; Mayer, S; Prendergast, MA | 1 |
| Arun, P; Devi, KV; Kurup, PA; Ravikumar, A | 1 |
| Bernardini, GL; Chong, JY; Commichau, C; Mayer, SA; Min, KC; Ridgway, E | 1 |
| Telengator, AIa | 1 |
| Cardis, F | 1 |
| Mitkov, V; Shekerova, N; Vasileva, D | 1 |
| Ivanchev, V | 1 |
| Graham, JG; Oppenheimer, DR | 1 |
2 review(s) available for nicotine and Nervous System Diseases
| Article | Year |
|---|---|
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives.
Topics: Amides; Animals; Endocannabinoids; Ethanolamines; Humans; Molecular Targeted Therapy; Nervous System Diseases; Nicotine; Oleic Acids; Palmitic Acids; PPAR alpha; Receptors, Nicotinic; Tobacco Use Disorder | 2014 |
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.
Topics: Animals; Arachidonic Acids; Dopamine; Dopaminergic Neurons; Endocannabinoids; Glycerides; Humans; Mesencephalon; Motivation; Nervous System Diseases; Nicotine; Receptor, Cannabinoid, CB1; Receptors, GABA; Reward; Substance-Related Disorders; Synaptic Transmission | 2012 |
1 trial(s) available for nicotine and Nervous System Diseases
| Article | Year |
|---|---|
Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
Topics: Algorithms; Central Nervous System Stimulants; Chewing Gum; Female; Gastrointestinal Diseases; Heart Diseases; Humans; Hypertension; Male; Middle Aged; Nervous System Diseases; Nicotine; Polymethacrylic Acids; Polyvinyls; Respiratory Tract Diseases; Smoking Cessation; Tablets; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States | 2005 |
16 other study(ies) available for nicotine and Nervous System Diseases
| Article | Year |
|---|---|
Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity.
Topics: Animals; Brain; COVID-19; Disease Models, Animal; Lung; Mice; Mice, Transgenic; Nervous System Diseases; Nicotine; RNA, Viral; SARS-CoV-2 | 2023 |
Does in utero exposure to heavy maternal smoking induce nicotine withdrawal symptoms in neonates?
Topics: Adult; Cotinine; Female; Fetal Blood; Humans; Infant; Infant, Newborn; Maternal Exposure; Maternal-Fetal Exchange; Nervous System Diseases; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking; Statistics as Topic; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2004 |
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates.
Topics: Adult; Alaska; Cotinine; Feasibility Studies; Female; Fetal Blood; Humans; Infant, Newborn; Infant, Newborn, Diseases; Inuit; Nervous System Diseases; Nicotine; Pilot Projects; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Smoking; Tobacco Use Disorder; Tobacco, Smokeless | 2005 |
Loosening addiction's deadly grip. Recent research paints a picture of addiction as a progressive, chronic neurological disease that wreaks havoc with brain chemistry.
Topics: Alcohol Drinking; Behavior, Addictive; Biomedical Research; Brain Chemistry; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Nervous System Diseases; Nicotine; Substance-Related Disorders | 2006 |
In utero exposure to smoking and newborn neurobehavior: how to assess neonatal withdrawal syndrome?
Topics: Female; Humans; Infant Behavior; Infant, Newborn; Maternal Exposure; Neonatal Abstinence Syndrome; Nervous System Diseases; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Smoking | 2006 |
Nicotine: a new neuroprotective agent?
Topics: Animals; Cholinergic Agents; Humans; N-Methylaspartate; Nervous System Diseases; Nicotine; Receptors, N-Methyl-D-Aspartate | 1994 |
Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity.
Topics: Acetylcholine; Animals; Carbachol; Cells, Cultured; Dimethylphenylpiperazinium Iodide; Hexamethonium; Mice; N-Methylaspartate; Neostriatum; Nerve Degeneration; Nervous System Diseases; Neurons; Nicotine; Receptors, Cholinergic; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic | 1994 |
Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants.
Topics: Cocaine; Confounding Factors, Epidemiologic; Cotinine; Female; Humans; Infant; Infant, Newborn; Logistic Models; Male; Meconium; Muscle Hypertonia; Nervous System Diseases; Neurologic Examination; Nicotine; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies; Smoking | 2000 |
Chronic, but not acute, nicotine exposure attenuates ethanol withdrawal-induced hippocampal damage in vitro.
Topics: Animals; Animals, Newborn; Culture Techniques; Dose-Response Relationship, Drug; Ethanol; Hippocampus; Mecamylamine; Nervous System Diseases; Nicotine; Propidium; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2000 |
Endogenous strychnine, nicotine, and morphine--description of hypo and hyper-strychninergic, nicotinergic and morphinergic state in relation to neuropsychiatric diseases.
Topics: Adult; Alkaloids; Brain Neoplasms; Chromatography, High Pressure Liquid; Erythrocyte Membrane; Glioma; Humans; Male; Mental Disorders; Middle Aged; Morphine; Neoplasm Proteins; Nervous System Diseases; Nicotine; Sodium-Potassium-Exchanging ATPase; Strychnine; Tryptophan; Tyrosine | 2000 |
Delirium from nicotine withdrawal in neuro-ICU patients.
Topics: Administration, Cutaneous; Adult; Aged; Delirium; Female; Humans; Intensive Care Units; Male; Nervous System Diseases; Nicotine; Substance Withdrawal Syndrome | 2001 |
[Smoking and the nervous system].
Topics: Humans; Nervous System; Nervous System Diseases; Nicotine; Smoking | 1987 |
[Tobacco and health].
Topics: Air Pollution; Cardiovascular Diseases; Christianity; Female; Gastrointestinal Diseases; Genital Diseases, Female; Humans; Male; Nervous System Diseases; Nicotine; Respiratory Tract Diseases; Smoking; Switzerland; Urologic Diseases | 1972 |
[Neurologic and similar diseases in workers and employees of the tobacco processing factory in the town of Plovdiv].
Topics: Bulgaria; Environmental Exposure; Female; Humans; Male; Nervous System Diseases; Nicotiana; Nicotine; Occupational Diseases; Plants, Toxic; Sex Factors | 1969 |
[On changes in certain indices of autonomic reactivity in tobacco fermentation room workers].
Topics: Adult; Air Pollution; Ammonia; Autonomic Nervous System; Carbon Dioxide; Humans; Methanol; Middle Aged; Nervous System Diseases; Nicotiana; Nicotine; Occupational Medicine; Plants, Toxic | 1968 |
Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy.
Topics: Atrophy; Brain; Cerebellar Diseases; Erectile Dysfunction; Humans; Hypotension, Orthostatic; Male; Middle Aged; Nervous System Diseases; Nicotine; Peripheral Nerves; Spinal Cord; Urinary Incontinence | 1969 |